A R T I C L E S
Brik et al.
2.68-2.75 (m, 1H), 2.61 (dd, J ) 15.4, 7.7, 1H), 1.98-1.95 (3s, 9H).
13C NMR (DMSO-d6, 500 MHz): δ 171.26, 170.03, 169.87, 169.41,
169.35, 156.82, 143.75, 143.73, 140.71, 140.69, 132.30, 127.64, 127.10,
125.23, 125.19, 120.11, 117.54, 80.70, 75.36, 72.08, 68.64, 65.80, 64.99,
61.99, 54.93, 50.42, 46.55, 38.23, 36.93, 20.70, 20.52, 20.43. HRMS
(ESI-TOF) calcd for C34H39N3O12 [M + H]+: 682.2606. Found:
682.2583.
Strategy: Fmoc Cleavage. After treatment with 10% piperidine/DMF
(2 × 5 min) the resin was washed (5× DMF, 5× DCM, 5× DMF).
Coupling. After preactivation of 4 equiv of protected amino acid
(final concentration 0.1 M in DMF) for 5 min using 4 equiv of PyBOP
and 8 equiv of NMM, the solution was added to the resin. After 30
min, the resin was washed with DMF (5×), DCM (5×), and DMF
(5×).
Compound 5. Compound 4 (2.0 g, 2.8 mmol) was added to
preactivated S-trityl-2-mercaptoactic acid (1.86, 5.6 mmol) with HBTU
(2.10 g, 5.6 mmol) and DIEA (2.0 mL, 11.2 mmoL) in dry DMF (20.0
mL). The reaction mixture was stirred at room temperature for 4 h,
diluted with 80 mL of ethyl acetate, and washed with water and brine.
The organic layer was dried over MgSO4 and concentrated for flash
Capping. Acetic anhydride/pyridine (1:9) was added to the resin.
After 5 min the resin was washed with DMF (5×), DCM (5×), and
DMF (5×).
Coupling of the Sugar-Containing Monomer. After preactivation
of 4 equiv of building block 6 (final concentration 0.1 M in DMF) for
5 min using 4 equiv of PyBOP and 8 equiv of NMM, the solution was
added to the resin. After 12 h, the resin was washed with DMF (5×),
DCM (5×), and DMF (5×).
1
column chromatography (EA/Hex 1:2) to give 2.0 g of 5 (89%). H
NMR (CDCl3, 500 MHz): δ 7.74 (d, J ) 7.4 Hz, 2H), 7.58 (d, J )
5.5 Hz, 2H), 7.18-7.39 (m, 22H), 6.03 (d, J ) 8.4 Hz, 1H), 5.77-
5.81 (m, 2H), 5.24 (d, J ) 17.3 Hz, 1H), 5.14 (d, J ) 10.3 Hz, 1H),
5.03 (dd, J ) 9.5, 9.5 Hz, 1H), 4.93 (dd, J ) 10.3, 10.3 Hz, 1H), 4.80
(dd, J ) 8.8, 8.8 Hz, 1H), 4.54-4.64 (m, 2H), 4.38-4.51 (m, 2H),
4.20-4.35 (m, 3H), 4.04 (d, J ) 12.1 Hz, 1H), 3.90-3.94 (m, 1H),
3.69 (d, J ) 8.1 Hz, 1H), 2.84-2.89 (m, 1H), 2.64-2.69 (m, 1H),
2.04 (s, 3H), 2.01 (s, 3H), 1.95 (s, 3H). 13C NMR (CDCl3, 500 MHz):
δ 171.51, 171.05, 170.75, 170.58, 169.21, 156.02, 143.82, 141.20,
141.17, 131.52, 129.34, 128.26, 127.62, 127.10, 126.99, 125.17, 125.10,
119.89, 118.33, 80.23, 73.39, 71.87, 68.00, 67.70, 6.17, 66.04, 61.54,
53.07, 50.34, 47.02, 37.47, 35.86, 20.65, 20.49. HRMS (ESI-TOF) calcd
for C55H55N3O13S [M + Na]+: 1020.3348. Found: 1020.3351.
Compound 6. Compound 5 (2.0 g, 2.0 mmol) was suspended in
THF (20 mL), and N-methylaniline (2.2 mL, 20 mmol) and (PPh3)4Pd
(231 mg, 0.2 mmol) were added subsequently. The reaction mixture
was stirred at room temperature for 1 h. After removing the solvent
under reduced pressure, the residue was subjected to column chroma-
tography (MeOH/CH3Cl 9:1) to give the product in 90% yield (1.8 g,
Cleavage. 1. Removal of the Acetyl Protecting Groups of the
Sugar. The resin was washed with MeOH (10×), treated with MeOH/
hydrazine 6:1 (2 × 2.5 h), and washed (10× MeOH, 5× DMF, 10×
DCM).
2. Cleavage from the Resin. A mixture of TFA, thioanisole,
triisopropylsilane, and water (17:1:1:1) was added. After 2 h, the resin
was washed with TFA (4 × 4 mL).
Workup. The combined solutions were concentrated in vacuo. The
residue was dissolved in water, purified by preparative HPLC, and
analyzed by MALDI-TOF/MS (matrix R-cyano-4-hydroxycinnamic
acid).
General Procedure for Chemical Ligation. The ligation of
unprotected glycopeptide segments was performed as follows: 0.1 M
phosphate buffer (pH 8.5) containing 6 M guanidine was degassed with
argon for 20 min before use. Peptide thioester and glycopeptide were
dissolved at a final concentration of 10 mM followed by the addtion
of 2% thiophenol. The ligation reaction was performed in a heating
block at 37 °C and was vortexed periodically to equilibrate the thiol
additive. Before analysis, TCEP (50 mM) was added to reduce any
disulfide bonds. The reaction was monitored using LCMS and/or
reverse-phase HPLC analysis performed on a Vydac C18 column using
a linear gradient (95-60%) of buffer A in buffer B over 30 min.
General Procedure for Desulfurization. Desulfurization reactions
were performed in a 0.1 M phosphate buffer containing 6.0 M guanidine
at pH 5.8 and 10 mM TCEP at room temperature. The buffer was
degassed by bubbling argon through for 20 min before each use. Pd/
Al2O3 was added (10-20 times the weight of peptide) and the reaction
was kept under hydrogen. The desulfurization reaction was monitored
by analytical HPLC as described above.
1
90%). H NMR (MeOD + CDCl3 (v/v ) 1/4), 500 MHz): δ 7.72-
7.77 (m, 2H), 7.55-7.64 (m, 3H), 7.50-7.55 (m, 1H), 7.34-7.41 (m,
3H), 7.24-7.31 (m, 7H), 7.18-7.23 (m, 5H), 7.11-7.15 (m, 2H), 5.15
(dd, J ) 10.3, 9.6 Hz, 2H), 5.10 (d, J ) 9.9 Hz, 1H), 4.96 (dd, J )
9.6, 9.6 Hz, 2H), 4.49 (m, 1H), 4.21-4.26 (m, 3H), 4.12 (dd, J ) 7.4,
7.4 Hz, 1H), 4.00-4.07 (m, 3H), 3.78-3.81 (m, 1H), 1.99 (s, 3H),
1.98 (s, 3H), 1.95 (s, 3H). 13C NMR (MeOD + CDCl3 (v/v ) 1/4),
500 MHz): δ 172.16, 171.65, 171.06, 145.10, 144.93, 144.77, 142.23,
142.21, 133.52, 133.49, 132.87, 132.79, 130.33, 129.76, 129.66, 129.57,
128.88, 128.56, 128.52, 127.94, 127.81, 127.79, 126.15, 126.08, 120.67,
79.28, 78.98, 74.32, 74.15, 69.59, 68.06, 67.96, 62.94, 53.61, 48.01,
38.89, 37.45, 20.75, 20.98. HRMS (ESI-TOF) calcd for C52H51N3O13S
[M + Na]+: 980.3035. Found: 980.3032.
Glycopeptide Synthesis. Solid-phase chemistry was carried out in
syringes equipped with Teflon filters, purchased from Torviq. If not
differently described, all reactions were carried out at room temperature.
Preparative HPLC was performed on a Hitachi (D-7000 HPLC system)
instrument using a preparative column (Grace Vydac “Protein &
Peptide” C18) and a flow rate of 9 mL/min. DMF was purchased from
Aldrich in biotech grade. Commercial reagents were used without
further purification. Resins, protected amino acids, and PyBOP were
purchased from Novabiochem.
Enzymatic Removal of the Glycan Moiety with N-Glycosidase
A. A total of 0.6 nmol of substrate (Table 1, entry 9, and its desulfurized
version, 1503.6 and 1471.3 Da) dissolved in 40 µL of pH 8.0, 50 mM
sodium phosphate buffer was mixed with N-glycosidase A (10 U,
purchased from New England Biolabs) and incubated at 37 °C. For
LCMS analysis, 2.5 µL of reaction solution was taken from the
Eppendorf tube and diluted into 35 µL of water.
Enzymatic Transfer. Glycopeptide product from entry 12, Table 1
(1.0 mg, 0.63 µmol) and UDP-Gal (0.6 mg, 1.0 µmol) were dissolved
in 110 µL of HEPES buffer (130 mM, pH 7.4 + 0.25% Triton X-100)
containing freshly prepared MnCl2 solution (0.95 µmol). â-1,4-GalT
(9.4 µL, 5 mU) and alkaline phosphatase (0.04 µL, 30 mU) were added,
and the reaction was shaken gently at ambient temperature for 40 h.
The reaction was then incubated with an excess of TCEP for 30 min
and purified by HPLC employing a gradient of 100:0 A:B to 10:90
A:B over 30 min at a flow rate of 1.5 mL min-1, where A ) 0.1%
TFA in H2O and B ) 0.1% TFA in MeCN. The retention time of the
desired product was 9.16 min. Lyophilization of the desired fractions
afforded pure disaccharide glycopeptide in 80% yield. Similar results
were obtained with the ligation product from entry 3, Table 1 (calcd
mass, 1605.7 Da; observed, 1606.4 Da).
Preloading of the Rink Amide Resin. The resin (0.69 mmol/g)
was washed (5× DCM, 5× DMF), followed by removal of the Fmoc
group by treating it with 10% piperidine/DMF (2 × 5 min) and another
washing step (5× DMF, 5× DCM, 5× DMF). For preactivation of the
first protected amino acid, 1 equiv of PyBOP and 2 equiv of NMM
were added to a solution of the building block (0.1 M) in DMF. After
5 min of preactivation, the mixture was added to the resin. After 2 h
the resin was washed (5× DMF, 5× DCM, 5× DMF), capped with
acetic anhydride/pyridine (1:9) (2 × 5 min), and washed (5× DMF,
5× DCM, 5× DMF).
Glycopeptide Solid-Phase Synthesis According to the Fmoc-
9
15032 J. AM. CHEM. SOC. VOL. 128, NO. 46, 2006